Atlas FDA

BIOSTOP G BIORESORBABLE CEMENT RESTRICTOR Catalog Numbers: 546308000 (Size 8); 546310000 (Size 10); 546312000 (Size 12);

FDA device recall Z-0951-2023 · posted 2023-01-12 · Open, Classified

Recall details

Recalling firm
Depuy Ireland UC
Reason for recall
All lots of BIOSTOP G Bioresorbable Cement Restrictor are being removed as a precautionary measure because tested endotoxin levels were higher than recommended by the current FDA regulatory guidance. In general, endotoxins have a potential to initiate inflammatory responses, ranging from a mild fever to potentially impact or damage to vital organs.
Action taken
On December 19, 2022, the firm notified affected consignees through "Urgent Medical Device Recall" letters. Customers were instructed to immediately identify and quarantine affected product in inventory. Recalled products should not be used. Customers should then contact Sedgwick at synthes5716@sedgwick.com or call 888-597-5387 to coordinate the return/credits of the subject products.
Root cause
Process control
Status
Open, Classified
Product code
LZN
Quantity affected
2199 US; 43515 OUS
Distribution
Worldwide distribution - US Nationwide and the countries of Argentina, Australia, Austria, Belgium, Brazil, Canada, Croatia, Czech Republic, Denmark, Finland, France, Germany, Great Britain, Hungary,
Date initiated
2022-12-19
Date posted
2023-01-12
Location
Ringaskiddy Co. Cork, Munster, Ireland

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
BIOSTOP G BONE CEMENT RESTRICTOR (K943727)Landos, Inc.1995-05-11